Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Takeda to divest consumer healthcare business to Blackstone for $2.3bn Japanese pharma giant Takeda Pharmaceutical has agreed to sell its consumer healthcare business to Oscar A-Co KK, a… bypharmanewsdailyAugust 24, 2020
